Literature DB >> 19959041

Clinical spectrum of pheochromocytoma.

Marlon A Guerrero1, Jennifer M J Schreinemakers, Menno R Vriens, Insoo Suh, Jimmy Hwang, Wen T Shen, Jessica Gosnell, Orlo H Clark, Quan-Yang Duh.   

Abstract

BACKGROUND: Pheochromocytomas vary in presentation, tumor size, and in catecholamine production. Whether pheochromocytoma size correlates with hormone levels, clinical presentation, and perioperative complications is not known. The goal of this study was to determine if tumor size and hormone level correlate according to the clinical presentation at diagnosis. STUDY
DESIGN: We retrospectively analyzed all patients who underwent an adrenalectomy with a diagnosis of a pheochromocytoma from February 1996 to October 2008. We grouped patients according to their clinical presentation at diagnosis (routine biochemical screening, incidentaloma, classic symptoms, pheochromocytoma crisis) and obtained preoperative radiographic tumor size and catecholamine hormone levels. ANOVA was used for the group effects and the Kruskal-Wallis rank test was used for pairwise comparison between groups with the Sidak/Bonferroni method for multiplicity adjustment according to age, tumor size, and hormone level. The Pearson correlation coefficient was then calculated to determine if hormone level correlated with tumor size.
RESULTS: Eighty-one of 107 patients had data available for complete analysis. The average age at diagnosis for all patients was 47.1 years, and the average tumor size was 4.9 cm. The average highest hormone ratio among all patients was 27.4. Tumor size and hormone ratio levels differed among all groups (p < or = 0.03). A direct correlation (p = 0.014) was apparent between tumor size and hormone level. Complication rates also differed among the four groups of patients (p < or = 0.02).
CONCLUSIONS: Our study showed that tumor size directly correlates with hormone level. Smaller tumors tend to secrete lower levels of catecholamines, but larger tumors have a wider variation in secretory potential. Larger tumors, however, produced the highest hormone ratios.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19959041     DOI: 10.1016/j.jamcollsurg.2009.09.022

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  50 in total

1.  Uncommon presentation, rare complication and previously undescribed oncologic association of pheochromocytoma; the great masquerader.

Authors:  David Lawrence; Kevan Salimian; Thorsten Leucker; Seth Martin
Journal:  BMJ Case Rep       Date:  2018-04-05

2.  [Treatment of an uncommon case of a cardiogenic shock : Simultaneous use of a VA-ECMO and an Impella-CP®].

Authors:  H Haake; K Grün-Himmelmann; U Kania; F Trudzinski; P M Lepper; J Vom Dahl
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-08-02       Impact factor: 0.840

Review 3.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

4.  Malignant pheochromocytoma with lung metastasis after right adrenalectomy for pheochromocytoma eleven years ago.

Authors:  Won Suk Choi; Jong Yoon Park; Mee Sook Roh; Pil Jo Choi
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

5.  Splenectomy for splenic metastases from malignant adrenal pheochromocytoma: a case report.

Authors:  Xiao-Feng Duan
Journal:  Cancer Biol Med       Date:  2013-06       Impact factor: 4.248

6.  Predictors of hemodynamic instability during surgery for pheochromocytoma.

Authors:  Colleen M Kiernan; Liping Du; Xi Chen; James T Broome; Chanjuan Shi; Mary F Peters; Carmen C Solorzano
Journal:  Ann Surg Oncol       Date:  2014-06-18       Impact factor: 5.344

7.  Pheochromocytoma diagnosed during pregnancy: lessons learned from a series of ten patients.

Authors:  G Donatini; J L Kraimps; C Caillard; E Mirallie; F Pierre; Loïc De Calan; A Hamy; O Larin; O Tovkay; S Cherenko
Journal:  Surg Endosc       Date:  2018-02-27       Impact factor: 4.584

Review 8.  Surgical approach to patients with pheochromocytoma.

Authors:  Dhaval Patel
Journal:  Gland Surg       Date:  2020-02

Review 9.  Current Consensus on I-131 MIBG Therapy.

Authors:  Daiki Kayano; Seigo Kinuya
Journal:  Nucl Med Mol Imaging       Date:  2018-05-03

Review 10.  Adrenal Incidentaloma.

Authors:  Mark Sherlock; Andrew Scarsbrook; Afroze Abbas; Sheila Fraser; Padiporn Limumpornpetch; Rosemary Dineen; Paul M Stewart
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.